Modified Delphi for Genomic Bereavement Care

Completed

• Conditions: Genetic Disease; Fetal Anomaly; Bereavement
• Interventions: Other: Questionnaire

• Registration Number: NCT05655741
• Lead Sponsor: The Leeds Teaching Hospitals NHS Trust

Brief Summary

It is estimated that 1 in 4 pregnancies end in loss, be these early miscarriages, ectopic pregnancies, or later intrauterine losses for any reason. Genomics is a major part of pregnancy loss, and clinicians want to offer the best and most appropriate test available to women and their families, whilst ensuring that there is equity in the access to this testing, so that no family goes through a loss without the right support and information. Whilst there is limited information to inform professionals as to how to incorporate genomics into bereavement care there is a need to identify current expert consensus as to how this should be performed, in order to make recommendations for best practice.

Detailed Description

There is a lack of guidance available as to how to care for women and families who suffer a pregnancy loss where fetal anomalies have been found and a genetic cause is suspected. As it is estimated that 1 in 4 pregnancies end in loss, these families make up a significant proportion of the population that maternity services care for and with no consensus in this area many families may have a poor experience.

As the field of genomics rapidly advances, it is important that patient care reflects the changes in practice and that the most appropriate tests and support are offered. All aspects of patient care will be reviewed including diagnosis, delivery, laboratory investigations, postnatal care and follow up in future pregnancies. The role of the genomics midwife will be explored and the role of the bereavement midwife will be further defined when it comes to support following pregnancy loss where there is likely an underlying genomic cause.

The aim of this modified delphi study is to understand what the current expert consensus is for genomic bereavement care. Using this, best practice guidance will be written that can be used within the NHS to better support families who suffer pregnancy loss during this pregnancy and in the future.

Study Timeline

• Study First Submitted: 2022-09-28
• Study Start: 2022-10-28
• Study First Submitted QC: 2022-12-16
• Study First Posted: 2022-12-19
• Primary Completion: 2023-03-17
• Study Completion: 2023-03-31
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-04
• Last Update Posted: 2023-04-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• Participants must belong to one of the relevant stakeholder groups; Maternal and fetal medicine consultants or obstetricians with a special interest in fetal medicine, Clinical geneticists with an interest in prenatal genomics, Perinatal pathologists Clinical scientists with an interest in genomics, Bereavement midwives.

Exclusion Criteria

• Nil if inclusion criteria are met

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Delphi Panel	Questionnaire	Participants who meet the inclusion criteria ,who are willing to complete the 3 questionnaires within the study.

Primary Outcome Measures

Name	Time	Method
Identify consensus for best practice for genomic bereavement care	26 weeks	Consensus will be achieved if \>80% of participants agree or strongly agree with the statement using a 5 point likert scale.

Trial Locations

Locations (1)

Leeds Teaching Hospitals Trust; 🇬🇧 Leeds, United Kingdom